Department of Neurology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
The Second Affiliated Hospital of Soochow University, Suzhou, China.
BMC Neurol. 2021 May 12;21(1):194. doi: 10.1186/s12883-021-02217-5.
The impact of nocturnal disturbance (ND) in Parkinson's disease on quality of life of patients in Western Countries is increasingly understood. Our study aimed to investigate ND prevalence and its quality of life impact in patients with advanced Parkinson's disease in China.
In a multicenter, tertiary-care hospital, outpatient-based, cross-sectional study, patients with advanced Parkinson's disease (Modified Hoehn & Yahr [H&Y] Stage II-IV with ≥3 h awake "off" time/day) from 10 tertiary hospitals throughout China completed the Parkinson's Disease Sleep Scale-2 (PDSS-2) and Parkinson's Disease Questionnaire-39 (PDQ-39). The primary endpoint was the percentage of patients with significant ND (PDSS-2 total score ≥ 15). Additional endpoints were demographic and clinical characteristics, PDSS-2 and PDQ-39 total and subscale scores, correlation between PDSS-2 and PDQ-39, and risk factors for ND and higher PDSS-2 or PDQ-39 scores.
Of 448 patients analyzed (mean age 63.5 years, 47.3% female), 70.92% (95% confidence interval: 66.71, 75.13) had significant ND. Presence of ND and higher PDSS-2 scores were associated with longer disease duration and higher H&Y stage. Presence of ND was also associated with more awake "off" time/day and female sex. PDQ-39 scores were significantly worse for patients with ND versus those without ND; worse scores were associated with more awake "off" time/day, female sex, and higher H&Y stage. PDSS-2 and PDQ-39 total scores were associated: Pearson correlation coefficient 0.62 (p < 0.001).
In China, ND was highly prevalent in patients with advanced Parkinson's disease and adversely impacted quality of life. This study highlights the importance of early diagnosis and optimized management of ND in patients with Parkinson's disease in China.
夜间干扰(ND)对西方国家帕金森病患者生活质量的影响越来越受到重视。我们的研究旨在调查中国晚期帕金森病患者 ND 的患病率及其对生活质量的影响。
在一项多中心、三级保健医院、基于门诊的横断面研究中,来自中国 10 家三级医院的 448 例晚期帕金森病患者(改良 Hoehn 和 Yahr [H&Y] 分期 II-IV 期,每天清醒“关”期≥3 小时)完成了帕金森病睡眠量表-2(PDSS-2)和帕金森病问卷-39(PDQ-39)。主要终点是有显著 ND(PDSS-2 总分≥15)的患者比例。其他终点包括人口统计学和临床特征、PDSS-2 和 PDQ-39 总分和子量表评分、PDSS-2 和 PDQ-39 之间的相关性以及 ND 和更高 PDSS-2 或 PDQ-39 评分的危险因素。
在分析的 448 例患者中(平均年龄 63.5 岁,47.3%为女性),70.92%(95%置信区间:66.71,75.13)有显著 ND。存在 ND 和更高的 PDSS-2 评分与疾病持续时间更长和 H&Y 分期更高有关。ND 的存在也与清醒“关”期时间更长和女性有关。与无 ND 的患者相比,有 ND 的患者 PDQ-39 评分明显更差;更差的评分与清醒“关”期时间更长、女性和更高的 H&Y 分期有关。PDSS-2 和 PDQ-39 总分之间存在关联:皮尔逊相关系数 0.62(p<0.001)。
在中国,晚期帕金森病患者 ND 的患病率很高,对生活质量有不利影响。这项研究强调了在中国帕金森病患者中早期诊断和优化 ND 管理的重要性。